Keyphrases
Opioids
100%
Bifunctional
100%
Nerve Injury
100%
Morphine Antinociception
80%
Physical Dependence
60%
Neuropathic Pain
60%
Opioid Agonist
60%
CCK Receptors
60%
Acute Pain
60%
High Affinity
40%
Nociception
40%
Pain States
40%
Receptor Antagonist
40%
Acute Injury
40%
Pathological Pain
40%
Antinociceptive Tolerance
40%
Pathological State
20%
Delta Opioid Agonist
20%
Novel Mechanism of Action
20%
Repeated Administration
20%
Antagonist Activity
20%
Inflammatory Pain
20%
Therapeutic Benefits
20%
Naloxone
20%
Co-agonist
20%
Opioid Antagonist
20%
Inflammation
20%
Receptor Activity
20%
δ Opioid Receptor
20%
μ-opioid Receptor
20%
Single Administration
20%
Delta Receptor
20%
Agonist Activity
20%
Chronic Pain
20%
Therapeutic Utility
20%
Morphine Antinociceptive Tolerance
20%
Novel Molecules
20%
Bifunctional Molecules
20%
Anti-opioid
20%
Pain Relief
20%
Medicine and Dentistry
Opiate
100%
Nerve Injury
100%
Cholecystokinin Receptor Blocking Agent
80%
Morphine-Induced Antinociception
80%
Opiate Agonist
60%
Substance Use Disorder
60%
Pain
60%
Neuropathic Pain
60%
Nociception
40%
Analgesia
20%
Chronic Pain
20%
Cholecystokinin Receptor
20%
Morphine
20%
Inflammatory Pain
20%
Opiate Antagonist
20%
Single Drug Dose
20%
μ-Opioid Receptor
20%
Repeated Drug Dose
20%
Delta Opiate Receptor
20%
Naloxone
20%
Delta Opioid Receptor
20%
Delta Opiate Receptor Agonist
20%
Drug Therapy
20%
Agonist-Antagonist
20%
Pharmacology, Toxicology and Pharmaceutical Science
Nerve Injury
100%
Opiate
100%
Cholecystokinin Receptor Blocking Agent
80%
Morphine-Induced Antinociception
80%
Drug Dependence
60%
Neuropathic Pain
60%
Pain
60%
Opiate Agonist
60%
Agonist-Antagonist
20%
μ-Opioid Receptor
20%
Inflammation
20%
Delta Opiate Receptor Agonist
20%
Morphine
20%
Opioid Antagonist
20%
Delta Opiate Receptor
20%
Inflammatory Pain
20%
Lead Compound
20%
Cholecystokinin Receptor
20%
Chronic Pain
20%
Naloxone
20%